Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Genome editing

This page shows the latest Genome editing news and features for those working in and with pharma, biotech and healthcare.

Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal

Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal

GRN. In November, Lilly signed a deal with Precision BioSciences focused on genome editing research, with an initial focus on developing in vivo therapies for Duchenne muscular dystrophy and two other

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    cells engineered to display chimeric antigen receptors) and genome editing (ie, CRISPR/Cas, TALEN, ZNF).

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    EDIT-101 is an experimental CRISPR genome-editing medicine that is currently being investigated by Editas for the treatment of Leber congenital amaurosis 10 (LCA10), an inherited eye condition. ... the genome, to better identify drug targets and increase

  • Deal Watch October 2018

    The agreement is for the development of therapies to eliminate the hepatits B virus (HBV) in vivo using the genome editing platform ARCUS.

  • Deal Watch March 2017 Deal Watch March 2017

    Editas Medicine has entered a strategic R&D alliance where Allergan has exclusive access to Editas’s CRISPR genome-editing programmes in ocular health, as well as options to license up ... 100. Editas. Allergan. R&D alliance. LCA10 and up to four other

  • Deal Watch May 2016 Deal Watch May 2016

    disease late last year, Bayer announced another gene editing pact this month with ERS Genomics. ... Bayer and ERS signed a patent licence agreement giving Bayer access to ERS' CRISPR-Cas9 genome-editing patents.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.

  • Editas Medicine adds to its board of directors Editas Medicine adds to its board of directors

    Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our

  • Editas Medicine adds to board of directors Editas Medicine adds to board of directors

    Dr Vaishnaw brings over 30 years of pharmaceuticals experience to the genome editing company, and currently serves as both executive vice president of research and development and chief medical officer at

  • Eric Rhodes becomes CEO of ERS Genomics Eric Rhodes becomes CEO of ERS Genomics

    In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development. ... Biosciences. Foy said: “With his deep understanding of the gene-editing landscape and extensive

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Creative Animodel

    Creative Animodel is an experienced bioscience CRO，which would like to help you accelerate the process through preclinical services including transgenic animals, animal models of disease, CRISPR genome editing technology and

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Because health means everything...

Latest intelligence

DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
THE EVOLVING ROLE OF PROCUREMENT?
Procurement is evolving to reinforce its position as a strategic enabler of company growth. How can agency partners organisations to realise this?...

Quick links